| 000 | 01857 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517162753.0 | ||
| 264 | 0 | _c20170804 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1421-9778 | ||
| 024 | 7 |
_a10.1159/000478067 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSu, Qiang | |
| 245 | 0 | 0 |
_aEffects of Trimetazidine on PDCD4/NF-κB/TNF-α Pathway in Coronary Microembolization. _h[electronic resource] |
| 260 |
_bCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology _c2017 |
||
| 300 |
_a753-760 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xgenetics |
| 650 | 0 | 4 |
_aCoronary Vessels _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEchocardiography |
| 650 | 0 | 4 |
_aEmbolism _xpathology |
| 650 | 0 | 4 |
_aHeart Injuries _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xadverse effects |
| 650 | 0 | 4 |
_aRNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSwine |
| 650 | 0 | 4 | _aSwine, Miniature |
| 650 | 0 | 4 |
_aTranscription Factor RelA _xgenetics |
| 650 | 0 | 4 |
_aTrimetazidine _xadministration & dosage |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
| 700 | 1 | _aLi, Lang | |
| 700 | 1 | _aZhao, Jinmin | |
| 700 | 1 | _aSun, Yuhan | |
| 700 | 1 | _aYang, Huafeng | |
| 773 | 0 |
_tCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology _gvol. 42 _gno. 2 _gp. 753-760 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000478067 _zAvailable from publisher's website |
| 999 |
_c27344101 _d27344101 |
||